Diabetes UK
| Use attributes for filter ! | |
| Headquarters | London |
|---|---|
| United Kingdom | |
| Ceo | Chris Askew |
| Founders | H. G. Wells |
| Founded | 1934 |
| Members | 180,000+ |
| Parent organizations | The British Diabetic Association |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2481167 |
About Diabetes UK
Diabetes UK is a British-based patient, healthcare professional and research charity that has been described as "one of the foremost diabetes charities in the UK". The charity campaigns for improvements in the care and treatment of people with diabetes.
Covid pandemic linked to surge in child and teen diabetes
... Dr Faye Riley, from Diabetes Uk, said: " Research worldwide has identified higher than expected numbers of diabetes diagnoses in the wake of the Covid-19 pandemic...
Poor diabetes care may be behind 7,000 excess deaths
... Diabetes Uk says too many people are still being " left to go it alone" when managing their challenging condition...
Activity snacking may help with type 1 diabetes - study
... Dr Elizabeth Robertson, director of research at Diabetes Uk, which funded the study, said for people with type 1 diabetes, managing blood sugar levels day in, day out, can be " relentless"...
New cabinet: Who is in Liz Truss's top team?
... The former magician s assistant is perhaps best known outside Westminster for appearing on ITV s celebrity diving show Splash! Before becoming MP for Portsmouth North in 2010 she was a press officer for Kensington and Chelsea Council and the Freight Transport Association, and a director of the Big Lottery Fund and Diabetes Uk...
Fear over high rates of diabetes foot amputations
... Diabetes Uk said the figures " shined a light on the scale of the crisis facing diabetes care" and it warned access to support was likely to have become worse during the pandemic...
Artificial pancreas to revolutionise diabetes care in England
... " Chris Askew, chief executive of Diabetes Uk, said: " This technology has the potential to transform the lives of people with type 1 diabetes, improving both their quality of life and clinical outcomes...
Covid: Vulnerable NHS patients to be offered new drug
... The chief executive of Diabetes Uk, Chris Askew, said: " People living with diabetes are at higher risk of becoming seriously ill with Covid-19...
Ramadan: fasting safely during coronavirus-crisis
... Diabetes Uk s head of care, Daniel Howarth said the decision was absolutely a personal reflection, but there were some precautions that could be taken by people with well managed conditions, the wanted, quickly, including eating slow-release carbohydrates, such as wholemeal bread and rice, and you test your blood sugar more often...
Covid: Vulnerable NHS patients to be offered new drug
A new Covid drug designed to reduce The Risk of vulnerable patients needing hospital treatment will be available on the NHS from today.
Sotrovimab is a monoclonal antibody given as a transfusion to transplant recipients, cancer patients and other high-risk groups.
If given quickly after symptoms develop it is should help prevent people from falling seriously ill with the Disease .
Initial tests suggest it should still work against the Omicron variant.
" These new drugs have an important role to play, " said Prof Steven Powis, The National medical director of Nhs England .
" If you test positive and are at High Risk then we will be contacting you, and, if eligible, you will be able to get access to these new treatments. "
Monoclonal antibodies
To date most Covid treatments have focused on patients already in hospital with the Disease - such as the cheap steroid dexamethasone and the arthritis drug Tocilizumab.
Now a Second Generation of Covid drugs are starting to come on Stream - aimed at vulnerable patients at an earlier stage of infection.
Initial clinical trials suggest sotrovimab, developed by GlaxoSmithKline (GSK) and Vir Biotechnology, is thought to reduce The Risk of hospitalisation in High Risk patients by 79%.
The drug works by binding to the spike protein on the outside of The Virus , preventing it from entering human cells, so that it cannot replicate in The Body .
GSK has said early laboratory tests suggest it should still work against the Omicron variant. More check are still needed, but researchers say the drug targets a part of the spike protein of The Virus that has not undergone major changes or mutations.
Around 1. 3 million of the highest risk NHS patients are eligible to receive Sotrovimab, along with other new Covid treatments as they become available.
The drug is most effective if taken in The First Five Days after infection and is likely to be given in clinics or to outpatients in hospital.
It has been approved for use in vulnerable groups - such as those with cancer, diabetes or heart Disease .
The Chief executive of Diabetes Uk , Chris Askew, said: " People living with diabetes are at higher risk of becoming seriously ill with Covid-19.
" Therapies that can keep people out of hospital are going to be important weapons as we look at this next period of coping with The Virus . "
It is understood The Department of Health has placed an initial order of 100,000 courses of the drug, which will be distributed across the whole UK.
Sotrovimab is The Second antibody treatment for Covid to be approved by regulators in the UK after another drug - Ronapreve - was cleared for use earlier this year.
To date, Ronapreve has mainly been used on hospitalised patients with weak immune systems who have not mounted an antibody response against Covid, where research shows it has cut deaths by a fifth.
Early laboratory studies by its developer, the US biotechnology company Regeneron, suggest it may work less well against Omicron than the previous Delta variant.
Vulnerable patients may also be offered a new antiviral pill, molnupiravir, which can be taken At Home and is.
LOOK-UP TOOL: SYMPTOMS: YOUR QUESTIONS: TREATMENTS: NEW VARIANTS:Source of news: bbc.com
